Skip to main content

Advertisement

Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Autophagy biomarkers in CSF correlates with infarct size, clinical severity and neurological outcome in AIS patients

Fig. 5

Relationship between autophagy biomarkers and outcome assessed by improvement in NIHSS in patients with AIS. a The NIHSS of AIS patients within 10–24 h of stroke onset and 3 months later. b CSF Beclin1 and LC3B levels in group of good outcome and poor outcome (Beclin1: p < 0.001; LC3B: p < 0.001). c Serum Beclin1 and LC3B in group of good outcome and poor outcome (Beclin1: p = 0.487; LC3B: p = 0.178)

Back to article page